Free ig light chains interact with sphingomyelin and are found on the surface of myeloma plasma cells in an aggregated form

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 4179-4188

  Hutchinson, Andrew T ^a   Ramsland, Paul A ^b,c   Jones, Darren R ^a   Agostino, Mark ^c   Lund, Maria E ^a   Jennings, Cameron V ^a   Bockhorni, Vanessa ^a   Yuriev, Elizabeth ^c   Edmundson, Allen B ^d   Raison, Robert L ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; KAPPA MYELOMA ANTIGEN; SPHINGOMYELIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN LIGHT CHAIN; MULTIPROTEIN COMPLEX;

ANTIGEN BINDING; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN AGGREGATE; INTERCALATION COMPLEX; MEMBRANE BINDING; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION; SECRETORY VESICLE; CAPPING PHENOMENON; CELL SEPARATION; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNOLOGY; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MEMBRANE; CELL SEPARATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MULTIPLE MYELOMA; MULTIPROTEIN COMPLEXES; PLASMA CELLS; RECEPTOR AGGREGATION; SPHINGOMYELINS; TRANSFECTION;

EID: 77958141571     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001956     Document Type: Article

References (43)

1. Kyle, R. A., and S. V. Rajkumar. 2008. Multiple myeloma. Blood 111:2962-2972.
2. Merlini, G., and V. Bellotti. 2003. Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349:583-596.
3. Sikkink, L. A., and M. Ramirez-Alvarado. 2008. Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases. Amyloid 15:29-39.
4. Qin, Z., D. Hu, M. Zhu, and A. L. Fink. 2007. Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation. Biochemistry 46:3521-3531.
5. Khurana, R., J. R. Gillespie, A. Talapatra, L. J. Minert, C. Ionescu-Zanetti, I. Millett, and A. L. Fink. 2001. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40:3525-3535.
6. Helms, L. R., and R. Wetzel. 1996. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. J. Mol. Biol. 257:77-86.
7. Meng, X., A. L. Fink, and V. N. Uversky. 2008. The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA. J. Mol. Biol. 381:989-999.
8. Rajkumar, S. V., R. A. Kyle, T. M. Therneau, R. J. Clark, A. R. Bradwell, L. J. Melton, III, D. R. Larson, M. F. Plevak, and J. A. Katzmann. 2004. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br. J. Haematol. 127:308-310.
9. Raison, R. L., and H. A. Boux. 1985. Conformation dependence of a monoclonal antibody defined epitope on free human kappa chains. Mol. Immunol. 22:1393-1398.
10. Boux, H. A., R. L. Raison, K. Z. Walker, G. E. Hayden, and A. Basten. 1983. A tumor-associated antigen specific for human κ myeloma cells. J. Exp. Med. 158:1769-1774.
11. Boux, H. A., R. L. Raison, K. Z. Walker, E. Musgrove, and A. Basten. 1984. The surface expression of a tumor-associated antigen on human κ myeloma cells. Eur. J. Immunol. 14:216-222.
12. Walker, K. Z., H. A. Boux, G. E. Hayden, C. C. Goodnow, and R. L. Raison. 1985. A monoclonal antibody with selectivity for human κ myeloma and lymphoma cells which has potential as a therapeutic agent. Adv. Exp. Med. Biol. 186:833-841.
13. Spencer, A., P. Walker, P. Asvadi, M. Wong, D. Campbell, K. Reed, M. Copeman, G. Nichol, L. J. Cohen, and R. Dunn. 2010. A phase I study of the anti-κ monoclonal antibody, MDX-1097, in previously treated multiple myeloma patients. J. Clin. Oncol. 28: S15 (Abstr. 8143).
14. Goodnow, C. C., and R. L. Raison. 1985. Structural analysis of the myelomaassociated membrane antigen KMA. J. Immunol. 135:1276-1280.
15. Gorbenko, G. P., and P. K. J. Kinnunen. 2006. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids 141:72-82.
16. Dixon, C., N. Mathias, R. M. Zweig, D. A. Davis, and D. S. Gross. 2005. α-Synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics 170:47-59.
17. Schweizer, A., O. Valdenaire, P. Nelböck, U. Deuschle, J. B. Dumas Milne Edwards, J. G. Stumpf, and B. M. Löffler. 1997. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem. J. 328:871-877.
18. Fujiki, Y., A. L. Hubbard, S. Fowler, and P. B. Lazarow. 1982. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J. Cell Biol. 93:97-102.
19. Koppel, D. E. 1972. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J. Chem. Phys. 57:4814-4821.
20. Hope, M. J., M. B. Bally, G. Webb, and P. R. Cullis. 1985. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 812:55-65.
21. Hojjati, M. R., and X. C. Jiang. 2006. Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J. Lipid Res. 47:673-676.
22. Roussel, A., S. Spinelli, S. Déret, J. Navaza, P. Aucouturier, and C. Cambillau. 1999. The structure of an entire noncovalent immunoglobulin κ light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association. Eur. J. Biochem. 260:192-199.
23. Hutt, D. M., L. F. Da-Silva, L. H. Chang, D. C. Prosser, and J. K. Ngsee. 2000. PRA1 inhibits the extraction of membrane-bound Rab GTPase by GDI1. J. Biol. Chem. 275:18511-18519.
24. David, V., F. Hochstenbach, S. Rajagopalan, and M. B. Brenner. 1993. Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). J. Biol. Chem. 268:9585-9592.
25. Boonsirichai, K., J. C. Sedbrook, R. Chen, S. Gilroy, and P. H. Masson. 2003. Altered Response to Gravity is a peripheral membrane protein that modulates gravity-induced cytoplasmic alkalinization and lateral auxin transport in plant statocytes. Plant Cell 15:2612-2625.
26. Drenan, R. M., X. Liu, P. G. Bertram, and X. F. Zheng. 2004. FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus. J. Biol. Chem. 279:772-778.
27. Vallas, V., W. Farrugia, R. L. Raison, A. B. Edmundson, and P. A. Ramsland. 2007. Dissimilar aggregation processes govern precipitation and gelation of human IgM cryoglobulins. J. Mol. Recognit. 20:90-96.
28. Yamaji, A., Y. Sekizawa, K. Emoto, H. Sakuraba, K. Inoue, H. Kobayashi, and M. Umeda. 1998. Lysenin, a novel sphingomyelin-specific binding protein. J. Biol. Chem. 273:5300-5306.
29. Shakor, A. B. A., E. A. Czurylo, and A. Sobota. 2003. Lysenin, a unique sphingomyelin-binding protein. FEBS Lett. 542:1-6.
30. Tomiuk, S., K. Hofmann, M. Nix, M. Zumbansen, and W. Stoffel. 1998. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl. Acad. Sci. USA 95:3638-3643.
31. Luberto, C., D. F. Hassler, P. Signorelli, Y. Okamoto, H. Sawai, E. Boros, D. J. Hazen-Martin, L. M. Obeid, Y. A. Hannun, and G. K. Smith. 2002. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J. Biol. Chem. 277:41128-41139.
32. Ramsland, P. A., W. Farrugia, E. Yuriev, A. B. Edmundson, and M. S. Sandrin. 2003. Evidence for structurally conserved recognition of the major carbohydrate xenoantigen by natural antibodies. Cell. Mol. Biol. (Noisy-le-grand) 49:307-317.
33. Ramsland, P. A., E. Yuriev, and A. B. Edmundson. 2001. Immunoglobulin crossreactivity examined by library screening, crystallography and docking studies. Comb. Chem. High Throughput Screen. 4:397-408.
34. Jaenicke, R. 1995. Folding and association versus misfolding and aggregation of proteins. Philos. Trans. R. Soc. Lond. B Biol. Sci. 348:97-105.
35. Goloubinoff, P., and A. P. Ben-Zvi. 2006. Mechanisms of active solubilization of stable protein aggregates by molecular chaperones. In Protein Misfolding, Aggregation and Conformational Diseases: Part A: Protein Aggregation and Conformational Diseases. V. N. Uversky, and A. L. Fink, eds. Springer, New York, p. 165-174.
36. Wall, J. S., F. M. Ayoub, and P. S. O'Shea. 1996. A study of the interactions of an immunoglobulin light chain with artificial and B-lymphocyte membranes. Front. Biosci. 1: a46-a58. 37.
37. Schiffer, M., R. L. Girling, K. R. Ely, and A. B. Edmundson. 1973. Structure of a λ-type Bence-Jones protein at 3.5-Å resolution. Biochemistry 12:4620-4631.
38. Hanson, B. L., G. J. Bunick, J. M. Harp, and A. B. Edmundson. 2002. Mcg in 2030: new techniques for atomic position determination of immune complexes. J. Mol. Recognit. 15:297-305.
39. Fernández, A., and R. S. Berry. 2003. Proteins with H-bond packing defects are highly interactive with lipid bilayers: implications for amyloidogenesis. Proc. Natl. Acad. Sci. USA 100:2391-2396.
40. Farrugia, W., A. M. Scott, and P. A. Ramsland. 2009. A possible role for metallic ions in the carbohydrate cluster recognition displayed by a Lewis Y specific antibody. PLoS ONE 4: e7777.
41. Kaplan, D. R., J. R. Colca, and M. L. McDaniel. 1983. Insulin as a surface marker on isolated cells from rat pancreatic islets. J. Cell Biol. 97:433-437.
42. Jiménez, J. L., E. J. Nettleton, M. Bouchard, C. V. Robinson, C. M. Dobson, and H. R. Saibil. 2002. The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. USA 99:9196-9201.
43. Hua, Q. X., and M. A. Weiss. 2004. Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J. Biol. Chem. 279:21449-21460.